Spotlight
Memorials
Classifieds
Families First
VCAs
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Program
What kind of winter will we get this year? Cold and snowy, or mild and sunny? Get the WRAL Winter Weather Outlook tonight at 6
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
4
Next >
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
July 25, 2023
Tags
NXP Semiconductors NV
Packaging Corp of America
Zscaler Inc
From
CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
July 25, 2023
Tags
Wells Fargo & Co
Health & Science
Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Tuesday
July 18, 2023
Tags
Investing
Markets
Eisai Co Ltd
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Companies
Alzheimer's disease
Science
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Medicare health plans
Biogen Inc
Politics
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Social issues
Eisai Co Ltd
Health & Science
From
CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
July 07, 2023
Tags
TG Therapeutics Inc
Market Insider
Biogen Inc
From
CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
July 07, 2023
Tags
Levi Strauss & Co
Alibaba Group Holding Ltd
First Solar Inc
From
CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
July 07, 2023
Tags
Biotech and Pharmaceuticals
Biogen Inc
Science
From
CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
Politics
Biogen Inc
Breaking News: Business
From
CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
June 13, 2023
Tags
Biogen Inc
Market Insider
Morgan Stanley
From
CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
June 09, 2023
Tags
Social issues
Health & Science
Eisai Co Ltd
From
CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags
Alzheimer's disease
Biotechnology
U/S/ Economy
From
CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
May 15, 2023
Tags
Stock Picks
Business News
Biogen Inc
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
Eli Lilly and Co
Business News
Breaking News: Business
From
CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
May 03, 2023
Tags
Business
Western Alliance Bancorp
PacWest Bancorp
From
CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
May 01, 2023
Tags
Health & Science
Eisai Co Ltd
Business
From
CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
April 30, 2023
Tags
Health & Science
Quanterix Corp
CVS Health Corp
From
CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
April 26, 2023
Tags
Epidemics
Pandemics
US: News
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Eli Lilly and Co
Pharmaceuticals
Biotech and Pharmaceuticals
From
CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
April 25, 2023
Tags
Health & Science
Breaking news
Ionis Pharmaceuticals Inc
From
CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
April 06, 2023
Tags
Biogen Inc
Breaking News: Business
Biotech and Pharmaceuticals
From
CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
April 05, 2023
Tags
Health care industry
US: News
Biotech and Pharmaceuticals
From
CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
March 22, 2023
Tags
Health & Science
Pharmaceuticals
Breaking news
From
CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
March 20, 2023
Tags
Biotechnology
Companies
Business
From
CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
March 13, 2023
Tags
Biogen Inc
Politics
Business News
From
CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
March 06, 2023
Tags
Health & Science
Eisai Co Ltd
U/S/ Economy
From
CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
February 23, 2023
Tags
World News
Policy
Biotech and Pharmaceuticals
From
CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
February 17, 2023
Tags
Business
AutoNation Inc
Zebra Technologies Corp
From
CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
February 17, 2023
Tags
US Economy
Pandemics
Epidemics
From
CNBC.com News
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.